Data as of Q4 2025 (Dec 31, 2025)

Blue Owl Capital Holdings LP

โ€ขCIK: 1858703โ€ขFiling: Q4 2025

**Blue Owl Capital Holdings LP** manages $1.3B across a portfolio of 79 positions. The fund exhibits a significant concentration in **BLK**, holding $1,012.5M, representing the vast majority of its disclosed assets. Other notable allocations include **ENGN** at $30.3M and **NCDL** at $28.6M. This structure suggests a highly concentrated, large-cap focus within its current investment mandate.

Total AUM
$1.3B
QoQ Performance
+314.9%
Positions
76
Top 10 Concentration
90.1%
Latest Filing
Q4 2025

Top Holdings Allocation

BLK
BLK75.8%
ENGN2.3%
NCDL2.1%
OBDC2.0%
LRMR1.9%
CGEM1.8%
CMPX1.4%
HLLY1.3%

๐Ÿ“ˆ Biggest Buys

BLK
BLACKROCK INC COM
NEW
75.8% of portfolio
PCOR
PROCORE TECHNOLOGIES INC
NEW
0.5% of portfolio
MPLT
MAPLIGHT THERAPEUTICS INC
NEW
0.4% of portfolio
IMMX
IMMIX BIOPHARMA INC
NEW
0.4% of portfolio
CMPX
COMPASS THERAPEUTICS INC
+33.8%
1.4% of portfolio

๐Ÿ“‰ Biggest Sells

ROIV
ROIVANT SCIENCES LTD
-73.4%
0.4% of portfolio
NCDL
NUVEEN CHURCHILL DIRECT LEND
-30.7%
2.1% of portfolio
PVLA
PALVELLA THERAPEUTICS INC NE
-57.7%
0.3% of portfolio
RARE
ULTRAGENYX PHARMACEUTICAL IN
-49.7%
0.4% of portfolio
AQST
AQUESTIVE THERAPEUTICS INC
-58.0%
0.3% of portfolio

Sector Breakdown

Financial75.8%
Other24.2%

๐Ÿšช Exited Positionssold since Q3 2025

EVCM
EVERCOMMERCE INC
SOLD
$18.3M
IRON
DISC MEDICINE INC
SOLD
$6.8M
KRRO
KORRO BIO INC
SOLD
$5.0M
MREO
MEREO BIOPHARMA GROUP PLC
SOLD
$2.6M
ACLX
ARCELLX INC
SOLD
$2.2M
+5 more exited positions

Changes from Q3 2025

NEW17 new positions
โ†‘17 increased
โ†“13 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023